Jove
Visualize
お問い合わせ

関連する概念動画

Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Developmental Profile and Variability in Preschool-Age Children With Down Syndrome.

Journal of intellectual disability research : JIDR·2026
Same author

Clinical and patient-reported outcomes after drug-coated balloon angioplasty for femoropopliteal peripheral artery disease.

VASA. Zeitschrift fur Gefasskrankheiten·2026
Same author

Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism.

The New England journal of medicine·2026
Same author

Post-pulmonary embolism cardiac impairment and chronic thromboembolic pulmonary hypertension after ultrasound-assisted catheter-directed thrombolysis for acute pulmonary embolism.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease.

The New England journal of medicine·2026
Same author

Correction: Ficany et al. Epistaxis Prevention, Treatment, and Future Perspectives for Hereditary Hemorrhagic Telangiectasia. <i>J. Clin. Med.</i> 2025, <i>14</i>, 7724.

Journal of clinical medicine·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

Updated: May 9, 2026

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
09:22

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet

Published on: November 5, 2015

12.7K

大規模な肺栓塞症である.

Nils Kucher1, Elisa Rossi, Marisa De Rosa

  • 1Cardiovascular Division, Department of Medicine, University Hospital Zurich, Zurich, Switzerland.

Circulation
|January 25, 2006
PubMed
まとめ

大量の肺栓塞 (PE) 治療の結果は,血栓溶解が生存率を向上させなかったことを示すが,下静脈 (IVC) フィルターは死亡率を低下させる可能性がある. 大量のPE患者におけるIVCフィルターの有効性については,さらなる研究が必要である.

科学分野:

  • 心臓病学 心臓病学
  • 肺内医学 肺内医学 肺内医学
  • クリティカルケア・メディシン

背景:

  • 急性多発性肺栓塞 (PE) は,高い死亡率と関連しています.
  • トロンボリシスや下静脈穴 (IVC) フィルターなどの補助療法が,大規模なPE管理に使用されます.
  • これらの治療法が臨床結果に与える影響を理解することは極めて重要です.

研究 の 目的:

  • 大量のPE患者における血栓溶解とIVCフィルター配置の利用を調査する.
  • これらの補助療法の効果を大量PE患者の臨床結果に評価する.

主な方法:

  • 国際協同肺栓塞症レジストリ (ICOPER) のデータ分析.
  • 急性PE患者の2392人を含め,108人 (4.5%) が大規模なPE (静脈動脈圧<90mmHg) を特定しました.
  • 血栓溶解,エンボレクトミー,またはIVCフィルターを投与された患者と,投与されなかった患者との間のアウトカムの比較.

主要な成果:

  • 大量のPE患者では90日間の死亡率は52.4%で,大量のPEでない患者では14.7%でした.
  • 血栓駆除薬療法は90日間の死亡率 (46.3%対55.1%) や再発性PE率 (12%対12%) を有意に低下させなかった.

さらに関連する動画

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
08:02

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 26, 2024

922
A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 7, 2024

927

関連する実験動画

Last Updated: May 9, 2026

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
09:22

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet

Published on: November 5, 2015

12.7K
Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
08:02

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 26, 2024

922
A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 7, 2024

927
  • 下腔静脈 (IVC) フィルター配置は90日間の死亡率の低下 (危険比0.12) と再発性PEイベントの欠如と関連していました.
  • 結論:

    • ICOPERの大規模なPE患者の3分の2は,血栓溶解や栓切除術を受けませんでした.
    • 血栓溶解は,死亡率の利益または90日後に再発性PEの減少を示さなかった.
    • IVCフィルターに関連した潜在的な死亡率の減少は,さらなる調査を正当化します.